Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
The GIST The Unraveled YouTube session GLP1 RA A Surprise Entry (see blog for the video) was well named
No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: a pooled analysis of cardiovascular outcome trials
The GLP-1 class of medicines is almost 20 years old
The strongest suppression of phagocytosis activity was displayed by the extract, with 55.43% of phagocytizing cells
Source: New England Journal of Medicine - STEP 1 Trial 20% lower risk of heart attack and stroke SELECT trial showed semaglutide reduces major cardiovascular events (death, heart attack, stroke) by 20% in people with obesity
How to verify you're drawing the right milligram dose Before every injection, complete this three-step verification: Step 1: Read the vial label concentration The concentration appears on the vial label in one of these formats: "Tirzepatide 10 mg/mL" "Tirzepatide Injection 100 mg / 10 mL" (divide 100 by 10 = 10 mg/mL) "Tirzepatide for Injection, 50 mg per 5 mL" (divide 50 by 5 = 10 mg/mL) If the label shows only total milligrams ("Tirzepatide 30 mg") without volume, the concentration is in the pharmacy's dispensing instructions, the patient information sheet, or the prescription label on the box
)